Key result
Achieving normotension outweighs specific antihypertensive regimens for slowing CKD progression.
Why the study?
Does achieving normotension slow the progression of chronic kidney disease in patients with hypertension?
Population
Patients with hypertension and chronic kidney disease, including diabetic nephropathy, and experimental…
Design
Review
Authors
Loading...
Normotension should remain the primary target in hypertensive CKD; this Level 5 review leaves open whether specific regimens add benefit beyond BP control.
Does achieving normotension slow the progression of chronic kidney disease in patients with hypertension?
The review emphasizes that achieving normotension is more critical than the specific choice of antihypertensive regimen in slowing chronic kidney disease progression.
Griffin et al. (2006) conducted a review in Hypertension and chronic kidney disease. Achieving normotension vs. Specific antihypertensive regimens was evaluated. Achieving normotension per se is of predominant importance over the selection of particular antihypertensive regimens in slowing the progression of chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: